To verify the correlation between DUSP8 and miR-1825 expression in GBM patients, we performed a combined in situ hybridization/immunohistochemistry (ISH/IHC) for miR-1825/DUSP8 on 8 GBM cases (4 with high and 4 with low expression of DUSP8). Here, DUSP8 is linked to glioblastoma.